NUS Nu Skin Enterprises, Inc. Common Stock
Sobre Nu Skin Enterprises, Inc. Common Stock Visão geral da empresa da Wikipedia
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
Ler mais
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
History
In 1984, Nu Skin founders Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund launched a line of skincare products using only natural ingredients. The founders aimed to create skincare products and nutritional products without unnecessary fillers with the philosophy of “all of the good, none of the bad.”
The company first served the United States market and expanded operations to Canada in 1990. In 1991, the company began operations in Asia, starting in Hong Kong. In 1996, the company listed on the New York Stock Exchange.
In 1992, Nu Skin settled with five states that accused the company of deceptive advertising and overstating distributor income. In 1994, the company paid $1 million and signed a consent decree with the FTC prohibiting it from making deceptive product claims. In 1997, the company paid an additional $1.5 million to the FTC to settle allegations of unsubstantiated claims.
In 1998, Nu Skin acquired Generation Health, the parent company of the dietary supplement company Pharmanex. According to Women's Health Letter, the Pharmanex device was designed merely to help sell more supplements, since per Nu Skin's 2002 annual report, "as customers track their skin carotenoid content, we believe they will be motivated to consistently consume LifePak for longer periods of time."
In the late 1990s, Nu Skin invested in Big Planet, a multilevel marketing company selling Internet services. The New York Times wrote that Big Planet recruited people "even if they have little knowledge of the technology that they are supposed to be selling," with a Big Planet representative quoted: "I believe people who have never touched a computer before can become hugely wealthy in this business."
In 2009, Nu Skin began working with LifeGen Technologies, a genomics company based in Madison, Wisconsin. Nu Skin acquired LifeGen in December 2011. Nu Skin claims LifeGen's genetic database aided in the development of Nu Skin's products, launching the ageLOC brand.
In 2016, Nu Skin paid a $47 million class-action settlement, citing failure to disclose that its Chinese subsidiary did not register as the direct seller. Nu Skin paid $750k in fines to the United States Securities and Exchange Commission following allegations of a bribe that saw charity funds go to a Chinese politician.
In 2021, Nu Skin's subsidiary Rhyz Inc. acquired social commerce company Mavely and acquired Dallas-based skincare company BeautyBio in 2023. In 2025, the company sold the Mavely platform for five times what it paid for the company in 2021, in a $250 million transaction to Later, the Summit Partners company.
Products
Nu Skin was granted a patent on a device developed by Pharmanex called a "BioPhotonic Scanner", which is designed to measure the carotenoid level in skin. The company launched its ageLOC anti-aging brand in 2008.
In 2014, Nu Skin launched the Nu Skin Facial Spa which received FDA clearance for over-the-counter cosmetic use. In 2018, the company introduced the ageLOC LumiSpa, a dual-action skin care device that uses a soft silicone treatment head to gently cleanse away dirt, oil, and makeup.
Nu Skin launched ageLOC LumiSpa iO, the company's first connected device, in 2022. LumiSpa iO is a smart treatment and cleansing device for customized skin care, popularized by Venus Williams. Nu Skin launched Nu Colour “Lash + Brow” in 2023, marketed as free of prostaglandins. In 2022, Nu Skin launched a line of Nutricentials Bioadaptive Skin Care Pumps. In 2024, the company launched Nu Skin RenuSpa iO, an FDA-cleared microcurrent body device with a connected app to view live insights during treatment. RenuSpa iO is the company's first integrated beauty and wellness device. In 2024, Nu Skin launched MYND360 as a supplement and topicals product line for cognitive health.
Reception
Nu Skin Enterprises' is a multi-level marketing business. Each distributor markets products directly to potential customers and may also recruit and train customers to become distributors. Distributors are paid on the retail markup on products they are able to sell, as well as a performance bonus based on the sales of recruited distributors. In the early 1990s, Nu Skin was investigated by Connecticut, Pennsylvania, Florida, Illinois, Ohio, and Michigan over allegations of misleading marketing practices. In 1992 the company settled with five of the states, admitted no wrongdoing but agreed to pay the states' investigative costs, refund distributors, and revamp its promotional practices. The Connecticut Attorney General did not agree to those terms and sued Nu Skin, alleging the company misled its distributors and operated a pyramid scheme. Nu Skin admitted to no wrongdoing or violation of law and settled with the state for $85k for consumer-protection programs.
In 1997, the Attorney General of Pennsylvania alleged in a lawsuit that Nu Skin operated a pyramid scheme through a subsidiary, QIQ Connections and that distributors paid for the right to market technology services that did not, in fact, exist. Nu Skin discontinued the QIQ subsidiary, allowing those who had paid QIQ to move to Big Planet, a Nu Skin investment marketing Internet technology. The president of Big Planet described the allegations as a matter of "a few distributors who in their enthusiasm have been overzealous in some of their marketing activities."
In 2010, Nu Skin was listed among Forbes "100 Most Trustworthy Companies".
In 2011, two Utah-incorporated business entities linked to top executives of Nu Skin each made a $1 million contribution to Restore Our Future, a Super PAC established by former aides to U.S. presidential candidate Mitt Romney to support his bid for the White House.
In 2012, Stanford University apologized for an misunderstanding following a cease and desist letter sent to halt the use of the name of one of its researchers, Dr. Stuart Kim, in Nu Skin's advertising. Also in 2012, Citron Research issued a report "stating that Nu Skin's sales model on mainland China, the fastest growing market in direct-selling, amounted to an illegal multilevel marketing scheme." Nu Skin dismissed the claims, calling its sales model in China "kosher" and stating that it had no plans to change its business model. In 2014, The Chinese government investigated Nu Skin following a People's Daily newspaper report calling it a "suspected illegal pyramid scheme." Following the investigation, the Chinese government fined Nu Skin for $540k due to illegal sales and making false product claims.
In February 2014, a press release shows a class action lawsuit filed in the U.S. District Court for the District of Utah against Nu Skin Enterprises on behalf of investors who acquired stock of the company from July 2013, to January 2014.
In a Last Week Tonight with John Oliver segment that covered multilevel marketing companies, Oliver criticized Nu Skin for the fact that in 2015, 93% of its distributors did not earn a commission check in a typical month. Nu Skin says it pays approximately 43 percent of its product revenue in sales compensation.
In 2025, Nu Skin was named to USA Today's list of "best customer service."
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
NUS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
NUS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor |
|---|---|
| 29 de Maio de 2026 | $0,0600 |
| 27 de Fevereiro de 2026 | $0,0600 |
| 28 de Novembro de 2025 | $0,0600 |
| 29 de Agosto de 2025 | $0,0600 |
| 30 de Maio de 2025 | $0,0600 |
| 24 de Fevereiro de 2025 | $0,0600 |
| 29 de Novembro de 2024 | $0,0600 |
| 30 de Agosto de 2024 | $0,0600 |
| 31 de Maio de 2024 | $0,0600 |
| 23 de Fevereiro de 2024 | $0,0600 |
| 22 de Novembro de 2023 | $0,3900 |
| 24 de Agosto de 2023 | $0,3900 |
| 25 de Maio de 2023 | $0,3900 |
| 24 de Fevereiro de 2023 | $0,3900 |
| 23 de Novembro de 2022 | $0,3850 |
| 25 de Agosto de 2022 | $0,3850 |
| 26 de Maio de 2022 | $0,3850 |
| 25 de Fevereiro de 2022 | $0,3850 |
| 24 de Novembro de 2021 | $0,3800 |
| 26 de Agosto de 2021 | $0,3800 |
NUS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 0 0,0%
- Compra 0 0,0%
- Manter 3 37,5%
- Venda 4 50,0%
- Venda forte 1 12,5%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $0.20 | $0.20 | -0.00% |
| 31 de Março de 2026 | $0.14 | $0.15 | -0.01% |
| 31 de Dezembro de 2025 | $0.29 | $0.30 | -0.01% |
| 30 de Setembro de 2025 | $0.34 | $0.30 | 0.04% |
| 30 de Junho de 2025 | $0.43 | $0.25 | 0.18% |
| 31 de Março de 2025 | $0.23 | $0.13 | 0.10% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| NUS | — | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| HNST | $291M | -18.4 | -1.9% | -4.2% | -8.8% | 33.3% |
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
| FTLF | — | 25.8 | 26.4% | — | — | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B | $2.25B | |
| Cost of Revenue | $454M | $550M | $612M | $631M | $675M | $658M | $581M | $634M | $502M | $500M | $490M | |
| Gross Profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B | $1.76B | |
| R&D Expense | $11M | $13M | $23M | $23M | $27M | $23M | $30M | $23M | $22M | $24M | $20M | |
| SG&A Expense | $432M | $479M | $547M | $556M | $654M | $636M | $616M | $662M | $565M | $554M | $561M | |
| Operating Expenses | $966M | $1.33B | $1.31B | $1.48B | $1.79B | $1.67B | $1.57B | $1.80B | $1.50B | $1.48B | $1.51B | |
| Operating Income | $66M | $-152M | $48M | $111M | $234M | $258M | $267M | $241M | $274M | $231M | $245M | |
| Interest Expense | · | · | $26M | $14M | $11M | $13M | $19M | $22M | $22M | $16M | $8M | |
| Other Non-op | $-32M | $3M | $4M | $-8M | $-2M | $-1M | $-12M | $-21M | $-9M | $-18M | $-33M | |
| Pretax Income | $196M | $-175M | $27M | $89M | $232M | $256M | $255M | $220M | $266M | $213M | $212M | |
| Income Tax | $36M | $-28M | $18M | $-16M | $85M | $65M | $82M | $98M | $136M | $70M | $79M | |
| Net Income | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | $143M | $133M | |
| EPS (Basic) | $3.25 | $-2.95 | $0.17 | $2.10 | $2.93 | $3.66 | $3.13 | $2.21 | $2.45 | $2.58 | $2.29 | |
| EPS (Diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 | $2.25 | |
| Shares (Basic) | 49,293,000 | 49,662,000 | 49,711,000 | 50,002,000 | 50,193,000 | 52,296,000 | 55,518,000 | 55,170,000 | 52,806,000 | 55,412,000 | 57,997,000 | |
| Shares (Diluted) | 50,301,000 | 49,662,000 | 49,860,000 | 50,525,000 | 51,427,000 | 52,765,000 | 55,927,000 | 56,476,000 | 54,852,000 | 56,097,000 | 59,057,000 | |
| EBITDA | $118M | $-82M | $119M | $183M | $310M | $332M | $344M | $324M | $346M | · | $316M |
Balanço Patrimonial 29
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $239M | $187M | $256M | $265M | $340M | $403M | $336M | $387M | $426M | $357M | $289M | |
| Short-term Investments | $1M | $11M | $12M | $14M | $15M | $21M | $8M | $11M | $12M | $11M | $14M | |
| Receivables | $40M | $51M | $59M | $47M | $41M | $63M | $50M | · | · | · | · | |
| Inventory | $179M | $190M | $280M | $346M | $400M | $314M | $276M | $296M | $253M | $250M | $265M | |
| Prepaid Expense | $90M | $73M | $81M | $88M | $77M | $102M | $70M | $52M | $53M | $65M | $102M | |
| Other Current Assets | $13M | $14M | $18M | $18M | $18M | $15M | $16M | $16M | $14M | $13M | $14M | |
| Current Assets | $548M | $539M | $702M | $760M | $873M | $903M | $740M | $799M | $778M | $714M | $706M | |
| PP&E (Net) | $377M | $380M | $433M | $445M | $454M | $468M | $454M | $465M | $465M | $445M | $455M | |
| PP&E (Gross) | $768M | $733M | $788M | $787M | $819M | $818M | $785M | $788M | $751M | $678M | $666M | |
| Accum. Depreciation | $391M | $353M | $355M | $342M | $366M | $350M | $331M | $323M | $286M | $234M | $212M | |
| Goodwill | $84M | $84M | $218M | $206M | $206M | $203M | $197M | $197M | $115M | $115M | $112M | |
| Intangibles | $43M | $74M | $95M | $67M | $77M | $90M | $80M | $90M | $68M | $64M | $67M | |
| Other Non-current Assets | $280M | $298M | $248M | $244M | $175M | $138M | $154M | $144M | $165M | $136M | $165M | |
| Total Assets | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B | |
| Accounts Payable | $26M | $35M | $43M | $54M | $50M | $66M | $39M | $48M | $50M | $41M | $29M | |
| Accrued Liabilities | $218M | $218M | $254M | $280M | $372M | $447M | $290M | $323M | $319M | $275M | $311M | |
| Current Liabilities | $264M | $297M | $329M | $359M | $530M | $543M | $357M | $440M | $447M | $399M | $408M | |
| Capital Leases | $58M | $58M | $71M | $77M | $89M | $112M | $106M | $0 | · | · | · | |
| Deferred Tax | $310.0K | $345.0K | $522.0K | $439.0K | $2M | $626.0K | $11M | $18M | $37M | $643.0K | $16M | |
| Other Non-current Liabilities | $75M | $97M | $107M | $110M | $106M | $102M | $97M | $112M | $127M | $77M | $91M | |
| Total Liabilities | $600M | $817M | $987M | $924M | $994M | $1.06B | $894M | $913M | $885M | $810M | $680M | |
| Long-term Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | $417M | $254M | |
| Total Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | · | $250M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | |
| Retained Earnings | $1.86B | $1.71B | $1.87B | $1.94B | $1.91B | $1.84B | $1.73B | $1.64B | $1.61B | $1.56B | $1.49B | |
| Treasury Stock | $1.58B | $1.56B | $1.57B | $1.57B | $1.53B | $1.46B | $1.32B | $1.33B | $1.30B | $1.25B | $1.02B | |
| AOCI | $-116M | $-125M | $-100M | $-87M | $-74M | $-65M | $-85M | $-80M | $-66M | $-84M | $-71M | |
| Stockholders' Equity | $805M | $651M | $822M | $897M | $913M | $894M | $875M | $782M | $705M | $664M | $826M | |
| Liabilities + Equity | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B |
Fluxo de Caixa 19
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $52M | $70M | $71M | $73M | $76M | $74M | $77M | $83M | $72M | $72M | $71M | |
| Stock-based Comp | $24M | $15M | $16M | $12M | $23M | $24M | $10M | $27M | $19M | $9M | $7M | |
| Deferred Tax | $20.0K | $-55M | $-15M | $-51M | $6M | $-14M | $-288.0K | $-19M | $44M | $-181.0K | $21M | |
| Amort. of Intangibles | $7M | $12M | $12M | $10M | $12M | $10M | $13M | $18M | $8M | $8M | $9M | |
| Restructuring | · | · | · | · | · | · | $22M | $22M | · | · | · | |
| Other Non-cash | $-156M | $229M | $39M | $-30M | $-112M | $104M | $-82M | $-10M | $38M | · | $90M | |
| Operating Cash Flow | $80M | $112M | $119M | $108M | $142M | $379M | $178M | $203M | $303M | $275M | $322M | |
| CapEx | $34M | $42M | $58M | $59M | $69M | $64M | $66M | $70M | $60M | $50M | $57M | |
| Investing Cash Flow | $171M | $-38M | $-135M | $-67M | $-89M | $-79M | $-71M | $-109M | $-92M | $-58M | $-61M | |
| Debt Issued | $55M | $15M | $110M | $460M | $155M | $115M | $145M | $582M | $67M | $234M | $36M | |
| Net Debt Issued | $-170M | $-110M | $100M | $28M | $40M | $-28M | $-69M | $30M | $-36M | · | $36M | |
| Stock Repurchased | $20M | $0 | $13M | $70M | $80M | $144M | $825.0K | $70M | $72M | $247M | $164M | |
| Net Stock Activity | $-20M | $0 | $-13M | $-70M | $-80M | $-144M | $-825.0K | $-70M | $-72M | · | $-164M | |
| Dividends Paid | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | $78M | $81M | |
| Financing Cash Flow | $-202M | $-133M | $11M | $-100M | $-105M | $-245M | $-155M | $-117M | $-160M | $-135M | $-236M | |
| Net Change in Cash | $52M | $-69M | $-9M | $-75M | $-63M | $67M | $-51M | $-39M | $69M | $68M | $939.0K | |
| Taxes Paid | $41M | $30M | $32M | $42M | $96M | $56M | $98M | $123M | $78M | $123M | $50M | |
| Free Cash Flow | $46M | $70M | $60M | $49M | $73M | $315M | $112M | $132M | $242M | · | $265M | |
| Levered FCF | · | · | $52M | $33M | $66M | $306M | $99M | $120M | $232M | · | $261M |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | · | · | |
| Operating Margin | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% | 10.0% | 11.1% | 9.0% | 12.0% | · | · | |
| Net Margin | 10.8% | -8.5% | 0.44% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | · | · | |
| Pretax Margin | 13.2% | -10.1% | 1.4% | 4.0% | 8.6% | 9.9% | 10.5% | 8.2% | 11.7% | · | · | |
| EBITDA Margin | 8.0% | -4.7% | 6.0% | 8.2% | 11.5% | 12.8% | 14.2% | 12.1% | 15.2% | · | · | |
| ROA | 11.2% | -8.9% | 0.47% | 5.6% | 7.6% | 10.3% | 10.0% | 7.4% | 8.5% | · | 8.5% | |
| ROE | 22.0% | -19.9% | 1.0% | 11.6% | 16.3% | 21.6% | 20.9% | 16.4% | 18.9% | · | 15.0% | |
| ROIC | 5.2% | -12.2% | 1.2% | 10.0% | 11.5% | 15.6% | 14.7% | 11.0% | 12.2% | · | 14.3% |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 | 1.7 | 2.1 | 1.8 | 1.7 | · | 1.7 | |
| Quick Ratio | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 | 0.9 | 1.0 | 0.9 | 1.0 | · | 0.7 | |
| Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.6 | · | 0.3 | |
| LT Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | 1.9 | 8.2 | 21.3 | 19.7 | 13.9 | 11.0 | 12.4 | · | 31.0 |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 1.1 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.6 | 1.5 | · | · | |
| Inventory Turnover | 2.5 | 2.3 | 2.0 | 1.7 | 1.9 | 2.2 | 2.0 | 2.3 | 2.0 | · | 1.6 | |
| Receivables Turnover | 32.9 | 31.6 | 32.8 | 50.2 | 51.5 | 45.4 | · | · | · | · | · |
Taxas de Crescimento 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.3% | -12.0% | -11.5% | -17.4% | 4.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.6% | -13.7% | -8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -91.8% | -27.6% | -21.2% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 15.4% | · | -63.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.6% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -91.8% | -28.8% | -23.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 15.2% | · | -64.5% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | -31.5% | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 6
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | · | $2.25B | |
| Net Income TTM | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | · | $133M | |
| P/E | 3.0 | -2.3 | 114.2 | 20.4 | 17.7 | 15.0 | 13.2 | 28.4 | 28.9 | · | 16.8 | |
| Earnings Yield | 33.1% | -42.8% | 0.88% | 4.9% | 5.6% | 6.6% | 7.6% | 3.5% | 3.5% | · | 5.9% | |
| Payout Ratio | 7.4% | -8.1% | 903.1% | 73.5% | 51.8% | 41.0% | 47.4% | 66.1% | 58.8% | · | 61.0% | |
| Annual Payout | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | · | $81M |
Demonstração de Resultados 16
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320M | $321M | $370M | $364M | $386M | $364M | $446M | $430M | $439M | $417M | $489M | $499M | $500M | $481M | $522M | $538M | |
| Cost of Revenue | $102M | $106M | $108M | $107M | $120M | $118M | $166M | $129M | $132M | $123M | $136M | $207M | $136M | $134M | $148M | $174M | |
| Gross Profit | $218M | $214M | $262M | $257M | $266M | $247M | $279M | $301M | $307M | $294M | $352M | $292M | $365M | $348M | $375M | $364M | |
| SG&A Expense | $91M | $99M | $107M | $105M | $107M | $113M | $121M | $116M | $118M | $125M | $145M | $131M | $137M | $134M | $128M | $138M | |
| Operating Expenses | $278M | $210M | $239M | $235M | $235M | $257M | $332M | $283M | $433M | $285M | $336M | $319M | $322M | $332M | $347M | $385M | |
| Operating Income | $-59M | $4M | $23M | $22M | $31M | $-10M | $-53M | $18M | $-126M | $9M | $16M | $-26M | $43M | $16M | $27M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $6M | $7M | $7M | · | $8M | $6M | $5M | · | · | |
| Other Non-op | $-534.0K | $3M | $-1M | $-2M | $-843.0K | $-28M | $1M | $2M | $629.0K | $-396.0K | $633.0K | $-551.0K | $376.0K | $3M | $10M | $-9M | |
| Pretax Income | $-63M | $3M | $18M | $16M | $27M | $135M | $-58M | $13M | $-132M | $1M | $9M | $-34M | $37M | $15M | $24M | $-29M | |
| Income Tax | $187M | $763.0K | $4M | $-1M | $6M | $27M | $-22M | $5M | $-13M | $2M | $2M | $3M | $10M | $3M | $-33M | $-4M | |
| Net Income | $-250M | $2M | $14M | $17M | $21M | $108M | $-36M | $8M | $-118M | $-533.0K | $7M | $-37M | $27M | $11M | $57M | $-25M | |
| EPS (Basic) | $-5.14 | $0.04 | $0.31 | $0.35 | $0.43 | $2.16 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.16 | $-0.51 | |
| EPS (Diluted) | $-5.14 | $0.04 | $0.27 | $0.34 | $0.43 | $2.14 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.15 | $-0.51 | |
| Shares (Basic) | 48,596,000 | 48,202,000 | -99,310,000 | 49,398,000 | 49,441,000 | 49,764,000 | -99,271,000 | 49,707,000 | 49,688,000 | 49,538,000 | -99,723,000 | 49,859,000 | 49,931,000 | 49,644,000 | -100,556,000 | 50,199,000 | |
| Shares (Diluted) | 48,596,000 | 49,422,000 | -99,836,000 | 50,310,000 | 49,499,000 | 50,328,000 | -99,297,000 | 49,733,000 | 49,688,000 | 49,538,000 | -100,218,000 | 49,859,000 | 50,161,000 | 50,058,000 | -101,700,000 | 50,199,000 | |
| EBITDA | $-47M | $16M | · | $34M | $44M | $4M | · | $36M | $-108M | $27M | · | $-8M | $60M | $33M | · | $-2M |
Balanço Patrimonial 29
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $190M | $199M | $239M | $252M | $264M | $204M | $187M | $228M | $224M | $213M | · | $233M | $236M | $230M | · | $294M | |
| Short-term Investments | $2M | $2M | $1M | $1M | $1M | $10M | $11M | $10M | $9M | $9M | · | $17M | $17M | $17M | · | $14M | |
| Receivables | $49M | $45M | $40M | $49M | $60M | $57M | $51M | $69M | $72M | $67M | · | $77M | $67M | $60M | · | $48M | |
| Inventory | $191M | $179M | $179M | $179M | $180M | $189M | $190M | $248M | $244M | $265M | · | $291M | $372M | $367M | · | $327M | |
| Prepaid Expense | $76M | $99M | $90M | $68M | $66M | $66M | $73M | $99M | $106M | $94M | · | $83M | $101M | $100M | · | $94M | |
| Other Current Assets | · | · | $13M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $508M | $523M | $548M | $548M | $572M | $525M | $539M | $653M | $654M | $647M | · | $701M | $793M | $774M | · | $778M | |
| PP&E (Net) | $380M | $382M | $377M | $375M | $374M | $380M | $380M | $411M | $412M | $423M | · | $429M | $430M | $438M | · | $433M | |
| PP&E (Gross) | · | · | $768M | · | · | · | $733M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $391M | · | · | · | $353M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $5M | $84M | $84M | $84M | $84M | $84M | $84M | $100M | $100M | $231M | · | $229M | $229M | $206M | · | $206M | |
| Intangibles | $38M | $39M | $43M | $44M | $46M | $48M | $74M | $85M | $88M | $102M | · | $109M | $113M | $65M | · | $69M | |
| Other Non-current Assets | $126M | $279M | $280M | $293M | $291M | $276M | $298M | $248M | $243M | $246M | · | $238M | $234M | $243M | · | $172M | |
| Total Assets | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B | |
| Accounts Payable | $38M | $29M | $26M | $29M | $29M | $34M | $35M | $33M | $36M | $32M | · | $49M | $50M | $49M | · | $42M | |
| Accrued Liabilities | $199M | $208M | $218M | $206M | $220M | $207M | $218M | $247M | $242M | $247M | · | $245M | $256M | $276M | · | $281M | |
| Current Liabilities | $256M | $257M | $264M | $254M | $284M | $260M | $297M | $339M | $309M | $309M | · | $434M | $445M | $373M | · | $366M | |
| Capital Leases | $50M | $54M | $58M | $62M | $62M | $62M | $58M | $68M | $70M | $74M | · | $68M | $74M | $79M | · | $78M | |
| Deferred Tax | · | · | $310.0K | · | · | · | $345.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $79M | $68M | $75M | $99M | $96M | $96M | $97M | $95M | $93M | $95M | · | $106M | $111M | $108M | · | $95M | |
| Total Liabilities | $579M | $583M | $600M | $625M | $656M | $637M | $817M | $876M | $900M | $932M | · | $971M | $998M | $932M | · | $921M | |
| Long-term Debt | $214M | $224M | $224M | $229M | $249M | $239M | $394M | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Total Debt | $214M | $224M | · | $229M | $249M | $239M | · | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | · | $91.0K | $91.0K | $91.0K | · | $91.0K | |
| Retained Earnings | $1.61B | $1.86B | $1.86B | $1.85B | $1.83B | $1.82B | $1.71B | $1.75B | $1.75B | $1.87B | · | $1.88B | $1.94B | $1.93B | · | $1.90B | |
| Treasury Stock | $1.56B | $1.56B | $1.58B | $1.57B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | · | $1.57B | $1.56B | $1.56B | · | $1.56B | |
| AOCI | $-118M | $-118M | $-116M | $-117M | $-114M | $-124M | $-125M | $-105M | $-117M | $-111M | · | $-109M | $-101M | $-91M | · | $-109M | |
| Stockholders' Equity | $543M | $794M | $805M | $800M | $788M | $754M | $651M | $707M | $686M | $810M | · | $822M | $895M | $893M | · | $842M | |
| Liabilities + Equity | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B |
Fluxo de Caixa 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $13M | $12M | $13M | $14M | $16M | $17M | $18M | $18M | $19M | $18M | $17M | $17M | $19M | $18M | |
| Stock-based Comp | $1M | $4M | $3M | $6M | $6M | $9M | $3M | $3M | $4M | $4M | $3M | $4M | $5M | $4M | $3M | $3M | |
| Other Non-cash | · | $-22M | · | · | · | $-131M | · | · | · | $-19M | · | · | · | $-54M | · | · | |
| Operating Cash Flow | $11M | $-4M | $17M | $27M | $36M | $389.0K | $26M | $31M | $51M | $3M | $54M | $51M | $36M | $-22M | $26M | $28M | |
| CapEx | $6M | $14M | $11M | $10M | $18.0K | $14M | $13M | $9M | $8M | $12M | $20M | $12M | $15M | $11M | $14M | $25M | |
| Investing Cash Flow | $-6M | $-14M | $-10M | $-10M | $9M | $182M | $-14M | $-7M | $-9M | $-9M | $-15M | $-12M | $-93M | $-15M | $-13M | $-25M | |
| Debt Issued | $0 | $225M | $0 | $40M | $15M | $0 | $0 | $15M | $0 | $0 | $0 | $0 | $90M | $20M | $0 | $0 | |
| Net Debt Issued | · | $0 | · | · | · | $-155M | · | · | · | $-20M | · | · | · | $18M | · | · | |
| Stock Repurchased | $0 | $5M | $10M | $5M | $0 | $5M | $0 | $0 | $0 | $0 | $0 | $13M | $0 | $0 | $10M | $40M | |
| Net Stock Activity | · | $-5M | · | · | · | $-5M | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $19M | $19M | $19M | $19M | $19M | $19M | |
| Financing Cash Flow | $-13M | $-20M | $-19M | $-27M | $9M | $-166M | $-44M | $-29M | $-29M | $-32M | $-20M | $-38M | $68M | $1M | $-51M | $-61M | |
| Net Change in Cash | $-9M | $-40M | $-13M | $-12M | $60M | $17M | $-41M | $4M | $12M | $-44M | $23M | $-2M | $6M | $-35M | $-29M | $-70M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-9M | · | · | · | $-34M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | · | · | · |
Lucratividade 8
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.2% | 66.9% | · | 70.5% | 68.8% | 67.8% | · | 70.1% | 70.0% | 70.5% | · | 58.6% | 72.9% | 72.2% | · | 67.7% | |
| Operating Margin | -18.5% | 1.3% | · | 5.9% | 8.0% | -2.7% | · | 4.2% | -28.6% | 2.1% | · | -5.3% | 8.5% | 3.3% | · | -3.8% | |
| Net Margin | -78.0% | 0.57% | · | 4.7% | 5.5% | 29.5% | · | 1.9% | -26.9% | -0.13% | · | -7.4% | 5.4% | 2.4% | · | -4.7% | |
| Pretax Margin | -19.7% | 0.81% | · | 4.4% | 7.1% | 36.9% | · | 3.1% | -30.0% | 0.26% | · | -6.9% | 7.4% | 3.0% | · | -5.4% | |
| EBITDA Margin | -14.6% | 5.1% | · | 9.3% | 11.3% | 1.2% | · | 8.3% | -24.6% | 6.5% | · | -1.6% | 11.9% | 6.9% | · | -0.39% | |
| ROA | -19.5% | 0.13% | · | 1.1% | 1.4% | 6.9% | · | 0.49% | -6.8% | -0.03% | · | -2.1% | 1.4% | 0.61% | · | -1.4% | |
| ROE | -37.5% | 0.24% | · | 2.3% | 2.9% | 13.8% | · | 1.1% | -15.0% | -0.06% | · | -4.4% | 2.9% | 1.2% | · | -2.9% | |
| ROIC | -31.0% | 0.28% | · | 2.2% | 2.3% | -0.80% | · | 1.0% | -9.8% | -0.33% | · | -2.1% | 2.2% | 0.95% | · | -1.4% |
Liquidez e Solvência 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.0 | · | 2.2 | 2.0 | 2.0 | · | 1.9 | 2.1 | 2.1 | · | 1.6 | 1.8 | 2.1 | · | 2.1 | |
| Quick Ratio | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 1.0 | |
| Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.6 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.5 | 0.6 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | 2.8 | -18.7 | 1.2 | · | · | · | · | · | · |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 0.5 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.7 | 0.4 | 0.4 | · | 0.5 | |
| Receivables Turnover | 5.9 | 6.3 | · | 6.2 | 5.9 | 5.9 | · | 5.9 | 6.3 | 6.6 | · | 8.0 | 9.0 | 8.6 | · | 10.7 |
Avaliação (TTM) 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.39B | $1.44B | · | $1.54B | $1.62B | $1.65B | · | $1.79B | $1.86B | $1.90B | · | $2.02B | $2.08B | $2.18B | · | $2.34B | |
| Net Income TTM | $-210M | $148M | · | $154M | $19M | $-3M | · | $-147M | $-129M | $780.0K | · | $-24M | $47M | $59M | · | $97M | |
| P/E | -1.2 | 2.5 | · | 4.0 | 22.2 | -90.8 | · | -2.5 | -4.1 | 691.5 | · | -44.2 | 35.7 | 34.2 | · | 17.7 | |
| Earnings Yield | -82.0% | 40.5% | · | 25.3% | 4.5% | -1.1% | · | -40.2% | -24.6% | 0.14% | · | -2.3% | 2.8% | 2.9% | · | 5.7% | |
| Payout Ratio | · | 156.5% | · | · | · | 2.8% | · | · | · | -558.9% | · | · | · | 170.5% | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B |
| Margem Bruta % | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% |
| Margem Operacional % | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% |
| Lucro líquido | $160M | $-147M | $9M | $105M | $147M |
| EPS Diluído | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 |
| Índice de liquidez corrente | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 |
| Índice de Liquidez Seca | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $46M | $70M | $60M | $49M | $73M |
Últimas notícias Notícias recentes mencionando esta empresa
- This $9 Nuclear Energy Stock Could Be Worth $100 by 2030
- Um terço das pessoas diz que o diploma universitário não vale a pena, à medida que a investigação sobre os empréstimos estudantis começa
- Nuclear é a história da energia de 2026. Aqui estão 2 ações para possuir durante todo o ano.
- NuScale Powervs. Oklo: Qual ação nuclear é uma melhor compra em 2026?
- Oklo vs. NuScale Power em 2026. Qual deles realmente vale a pena comprar?
- 2 Ações de Energia Nuclear para Comprar em Maio
- Previsão: Ações da NuScale Power São uma Compra Antes de 2027 Devido a Esta Oportunidade de US$ 1,75 Trilhão
- Nu Skin Enterprises Destaques da Chamada de Lucros do 1º Trimestre
- NuScale Power caiu 82%. A história mostra que sobreviventes de crises como essa podem retornar 5x.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 188 declarantes · $157.3M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 34 (+13 vs trimestre anterior) | 33 (+6 vs trimestre anterior) | 51 (-14 vs trimestre anterior) | 54 (-4 vs trimestre anterior) | +4.8M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| AMERICAN CENTURY COMPANIES INC | $12.150.906 | 2.301.308 | 7,72% | Ações |
| Coppell Advisory Solutions LLC | $11.266.612 | 235 | 7,16% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.822.104 | 2.049.641 | 6,88% | Ações |
| Prescott Group Capital Management, L.L.C. | $9.475.530 | 1.794.608 | 6,02% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9.170.600 | 1.736.856 | 5,83% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $8.926.062 | 1.690.542 | 5,67% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $8.488.614 | 1.607.692 | 5,40% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.671.507 | 1.452.937 | 4,88% | Ações |
| CastleKnight Management LP | $7.337.262 | 1.389.633 | 4,66% | Ações |
| TWO SIGMA ADVISERS, LP | $7.314.086 | 760.300 | 4,65% | Ações |
| TWO SIGMA INVESTMENTS, LP | $6.170.388 | 1.168.634 | 3,92% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $5.745.042 | 1.087.765 | 3,65% | Ações |
| STATE STREET CORP | $5.330.941 | 1.009.648 | 3,39% | Ações |
| PRUDENTIAL FINANCIAL INC | $3.959.403 | 749.887 | 2,52% | Ações |
| CITADEL ADVISORS LLC | $3.337.140 | 632.034 | 2,12% | Ações |
| Bank of New York Mellon Corp | $2.377.067 | 450.202 | 1,51% | Ações |
| Allianz Asset Management GmbH | $2.074.074 | 392.817 | 1,32% | Ações |
| D. E. Shaw & Co., Inc. | $1.795.385 | 340.035 | 1,14% | Ações |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1.674.151 | 317.074 | 1,06% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $1.627.908 | 308.316 | 1,03% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $1.590.690 | 301.267 | 1,01% | Ações |
| AXA Investment Managers S.A. | $1.307.268 | 107.241 | 0,83% | Ações |
| GOLDMAN SACHS GROUP INC | $1.287.735 | 243.889 | 0,82% | Ações |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1.212.651 | 166.573 | 0,77% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.081.872 | 204.900 | 0,69% | Ações |
| VANGUARD GROUP INC | $1.074.333 | 111.677 | 0,68% | Ações |
| Vanguard Global Advisers, LLC | $936.603 | 177.387 | 0,60% | Ações |
| FIRST TRUST ADVISORS LP | $925.594 | 175.302 | 0,59% | Ações |
| XTX Topco Ltd | $823.379 | 155.943 | 0,52% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $803.590 | 152.195 | 0,51% | Ações |
| MARTINGALE ASSET MANAGEMENT L P | $799.852 | 151.487 | 0,51% | Ações |
| LAZARD ASSET MANAGEMENT LLC | $728.614 | 137.995 | 0,46% | Ações |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $670.856 | 127.056 | 0,43% | Ações |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $628.125 | 118.963 | 0,40% | Ações |
| ExodusPoint Capital Management, LP | $616.408 | 116.744 | 0,39% | Ações |
| Cubist Systematic Strategies, LLC | $571.087 | 46.849 | 0,36% | Ações |
| RITHOLTZ WEALTH MANAGEMENT | $527.566 | 99.918 | 0,34% | Ações |
| STRS OHIO | $511.104 | 96.800 | 0,32% | Ações |
| BlackRock, Inc. | $487.228 | 92.278 | 0,31% | Ações |
| ALLIANCEBERNSTEIN L.P. | $467.376 | 64.200 | 0,30% | Ações |
| Nebula Research & Development LLC | $460.288 | 57.608 | 0,29% | Ações |
| BANK OF AMERICA CORP /DE/ | $425.162 | 80.523 | 0,27% | Ações |
| SummerHaven Investment Management, LLC | $402.215 | 76.177 | 0,26% | Ações |
| EP Wealth Advisors, LLC | $387.314 | 73.355 | 0,25% | Ações |
| BARCLAYS PLC | $375.540 | 71.125 | 0,24% | Ações |
| Skopos Labs, Inc. | $373.217 | 51.266 | 0,24% | Ações |
| Russell Investments Group, Ltd. | $372.662 | 70.580 | 0,24% | Ações |
| RHUMBLINE ADVISERS | $332.444 | 62.965 | 0,21% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $326.631 | 61.862 | 0,21% | Ações |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $323.110 | 61.195 | 0,21% | Ações |
| Engineers Gate Manager LP | $314.688 | 59.600 | 0,20% | Ações |
| Campbell & CO Investment Adviser LLC | $299.571 | 56.737 | 0,19% | Ações |
| Graham Capital Management, L.P. | $297.649 | 56.373 | 0,19% | Ações |
| Cambria Investment Management, L.P. | $283.969 | 53.782 | 0,18% | Ações |
| EXCHANGE TRADED CONCEPTS, LLC | $281.276 | 53.272 | 0,18% | Ações |
| FEDERATED HERMES, INC. | $276.213 | 52.313 | 0,18% | Ações |
| WOLVERINE TRADING, LLC | $264.769 | 21.918 | 0,17% | Ações |
| DGS Capital Management, LLC | $263.128 | 36.144 | 0,17% | Ações |
| Quantinno Capital Management LP | $259.888 | 49.221 | 0,17% | Ações |
| DEUTSCHE BANK AG\ | $251.391 | 47.612 | 0,16% | Ações |
| Walleye Capital LLC | $248.947 | 47.149 | 0,16% | Ações |
| CWM, LLC | $242.924 | 33.369 | 0,15% | Ações |
| State of Tennessee, Department of Treasury | $227.648 | 43.115 | 0,14% | Ações |
| AMERIPRISE FINANCIAL INC | $225.055 | 42.624 | 0,14% | Ações |
| Aquatic Capital Management LLC | $223.634 | 42.355 | 0,14% | Ações |
| MANGROVE PARTNERS IM, LLC | $222.198 | 42.083 | 0,14% | Ações |
| WELLS FARGO & COMPANY/MN | $215.783 | 40.868 | 0,14% | Ações |
| Verdad Advisers, LP | $195.355 | 36.999 | 0,12% | Ações |
| FMR LLC | $173.791 | 32.915 | 0,11% | Ações |
| Y-Intercept (Hong Kong) Ltd | $172.767 | 32.721 | 0,11% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $170.544 | 32.300 | 0,11% | Ações |
| Range Financial Group LLC | $167.666 | 31.755 | 0,11% | Ações |
| State of Wyoming | $161.019 | 30.496 | 0,10% | Ações |
| Abel Hall, LLC | $149.112 | 28.241 | 0,09% | Ações |
| Empowered Funds, LLC | $146.351 | 27.718 | 0,09% | Ações |
| WOLVERINE TRADING, LLC | $143.752 | 11.900 | 0,09% | Opção de venda |
| MetLife Investment Management, LLC | $140.765 | 26.660 | 0,09% | Ações |
| Atom Investors LP | $140.078 | 26.530 | 0,09% | Ações |
| Susquehanna Portfolio Strategies, LLC | $139.561 | 26.432 | 0,09% | Ações |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $131.604 | 24.925 | 0,08% | Ações |
| HSBC HOLDINGS PLC | $127.773 | 24.619 | 0,08% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $121.567 | 23.024 | 0,08% | Ações |
| Vanguard Personalized Indexing Management, LLC | $120.410 | 22.805 | 0,08% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $118.642 | 22.470 | 0,08% | Ações |
| Creative Planning | $116.686 | 22.100 | 0,07% | Ações |
| Advisors Asset Management, Inc. | $115.366 | 16.744 | 0,07% | Ações |
| Aigen Investment Management, LP | $104.137 | 19.723 | 0,07% | Ações |
| CITIGROUP INC | $103.889 | 19.676 | 0,07% | Ações |
| Invesco Ltd. | $102.585 | 19.429 | 0,07% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $100.848 | 19.100 | 0,06% | Opção de venda |
| GLENMEDE TRUST CO NA | $100.541 | 19.042 | 0,06% | Ações |
| CITADEL ADVISORS LLC | $98.736 | 18.700 | 0,06% | Opção de venda |
| AlphaQuest LLC | $95.748 | 9.953 | 0,06% | Ações |
| Schonfeld Strategic Advisors LLC | $78.908 | 14.945 | 0,05% | Ações |
| Jain Global LLC | $76.032 | 14.400 | 0,05% | Ações |
| MEEDER ASSET MANAGEMENT INC | $72.975 | 13.821 | 0,05% | Ações |
| Police & Firemen's Retirement System of New Jersey | $72.695 | 13.768 | 0,05% | Ações |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $72.107 | 13.787 | 0,05% | Ações |
| BANK OF MONTREAL /CAN/ | $70.504 | 13.353 | 0,04% | Ações |
| PharVision Advisers, LLC | $69.707 | 13.202 | 0,04% | Ações |
Executivos da empresa 57 insiders · 31 diretores · 25 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Ryan S Napierski | President and CEO | 6 de Março de 2026 A | 1.001.905 | 0 | 0 | $0 |
| Ritch N Wood | Chief Executive Officer | 17 de Junho de 2021 S | 175.239 | 0 | 0 | $0 |
| Truman M Hunt | President & CEO | 27 de Fevereiro de 2017 A | 575.559 | 0 | 0 | $0 |
| James D Thomas | Chief Financial Officer | 6 de Março de 2026 A | 267.102 | 0 | 0 | $0 |
| Mark H Lawrence | Chief Financial Officer | 2 de Março de 2023 M | 57.146 | 0 | 0 | $0 |
| Scott E Schwerdt | President, Americas Region | 18 de Dezembro de 2015 A | 34.585 | 0 | 0 | $0 |
| Gary Sumihiro | President | 20 de Dezembro de 2007 A | 800 | 0 | 0 | $0 |
| Luke Loo | President | 20 de Dezembro de 2007 A | 5.625 | 0 | 0 | $0 |
| Larry V Macfarlane | President, Big Planet | 26 de Fevereiro de 2007 A | 6.005 | 0 | 0 | $0 |
| Robert S Conlee | President, North Asia & Japan | 26 de Fevereiro de 2007 A | 4.549 | 0 | 0 | $0 |
| Lori H Bush | President -Nu Skin Division | 31 de Agosto de 2005 A | 11.453 | 0 | 0 | $0 |
| Chayce David Clark | EVP, COO and CLO | 6 de Março de 2026 A | 390.746 | 0 | 1 | $-239.400 |
| Justin S Keisel | EVP, President of Global Sales | 6 de Março de 2026 A | 160.170 | 0 | 0 | $0 |
| Steven Keith Hatchett | Chief Product Officer | 6 de Março de 2026 A | 260.818 | 1 | 0 | $52.855 |
| Connie Mang Yee Tang | Chief Global Growth Officer | 21 de Abril de 2023 F | 43.204 | 0 | 0 | $0 |
| Joseph Y Chang | Chief Scientific Officer | 2 de Março de 2023 M | 21.234 | 0 | 0 | $0 |
| Steven Lund | Exec. Chairman of the Board | 1 de Março de 2023 G | 113.574 | 0 | 0 | $0 |
| Jeffrey Clark Bettinger | SVP, People and Places Officer | 5 de Outubro de 2021 S | 16.068 | 0 | 0 | $0 |
| Matthew D Dorny | General Counsel | 2 de Julho de 2021 M | 47.159 | 0 | 0 | $0 |
| Daniel R Chard | Pres Global Sales & Operations | 6 de Julho de 2015 M | 48.111 | 0 | 0 | $0 |
| Blake Roney | Chairman of the Board | 3 de Junho de 2011 G | 3.216.458 | 0 | 0 | $0 |
| Ashok Pahwa | Chief Marketing Officer | 28 de Agosto de 2009 F | 3.322 | 0 | 0 | $0 |
| Jack Peterson | Vice President | 20 de Dezembro de 2007 A | 6.984 | 0 | 0 | $0 |
| Mark L Adams | Chief Information Officer | 20 de Dezembro de 2007 A | 11.410 | 0 | 0 | $0 |
| Claire Averett | Vice President | 4 de Setembro de 2007 F | 3.230 | 0 | 0 | $0 |
| Brett Nelson | Vice President | 4 de Setembro de 2007 F | 4.202 | 0 | 0 | $0 |
| Corey B Lindley | Executive Vice President | 1 de Setembro de 2006 A | 20.750 | 0 | 0 | $0 |
| Mark Wolfert | Regional Vice President- | 31 de Agosto de 2005 A | 0 | 0 | 0 | $0 |
| Michael D Smith | Vice President-Gov't Relations | 31 de Agosto de 2005 A | 1.734 | 0 | 0 | $0 |
| Richard W King | Chief Information Officer | 31 de Agosto de 2005 A | 5.987 | 0 | 0 | $0 |
| Brooke Roney | Senior Vice President | 2 de Dezembro de 2004 G | 825.000 | 0 | 0 | $0 |
| Edwina D Woodbury | Conselheiro | 10 de Junho de 2026 A | 62.452 | 0 | 1 | $-41.057 |
| James M Winett | Conselheiro | 2 de Junho de 2026 S | 37.448 | 0 | 1 | $-40.481 |
| Laura Nathanson | Conselheiro | 1 de Junho de 2026 A | 57.116 | 0 | 2 | $-97.305 |
| Emma S. Battle | Conselheiro | 1 de Junho de 2026 A | 57.648 | 0 | 0 | $0 |
| Pisano R. Thomas | Conselheiro | 1 de Junho de 2026 A | 116.827 | 0 | 0 | $0 |
| Mark A Zorko | Conselheiro | 1 de Junho de 2026 A | 60.586 | 0 | 0 | $0 |
| Daniel W Campbell | Conselheiro | 1 de Junho de 2026 A | 65.859 | 0 | 2 | $-392.669 |
| Zheqing Shen | Conselheiro | 7 de Junho de 2024 A | 33.195 | 0 | 0 | $0 |
| Andrew D Lipman | Conselheiro | 28 de Maio de 2024 S | 23.225 | 0 | 0 | $0 |
| Neil H Offen | Conselheiro | 21 de Maio de 2019 M | 10.083 | 0 | 0 | $0 |
| Nevin N Andersen | Conselheiro | 21 de Maio de 2019 M | 34.045 | 0 | 0 | $0 |
| Zhequing Shen | Conselheiro | 11 de Maio de 2017 A | 3.456 | 0 | 0 | $0 |
| Patricia Negron | Conselheiro | 13 de Maio de 2015 G | 7.592 | 0 | 0 | $0 |
| Sandra Tillotson | Conselheiro | 4 de Maio de 2012 M | 1.885.845 | 0 | 0 | $0 |
| David D. Ussery | Conselheiro | 9 de Fevereiro de 2012 M | 13.222 | 0 | 0 | $0 |
| Ej Jake Garn | Conselheiro | 24 de Maio de 2011 A | 17.272 | 0 | 0 | $0 |
| Desmond C Wong | Conselheiro | 15 de Maio de 2007 A | 1.400 | 0 | 0 | $0 |
| Christine Mccormick Day | Conselheiro | 15 de Maio de 2007 A | 1.400 | 0 | 0 | $0 |
| Allen D Andersen | Conselheiro | 25 de Maio de 2006 A | 2.500 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 9 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 11 de Fevereiro de 2008 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 2 de Abril de 2007 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 26 de Março de 2007 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 15 de Março de 2007 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 8 de Dezembro de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 9 de Junho de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 8 de Maio de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 20 de Janeiro de 2006 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 15 de Dezembro de 2005 | — | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 47 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| DEEP · ETF Series Solutions | 0,71% | 32.178 NS | 31 de Maio de 2026 | N-PORT |
| MYLD · Cambria ETF Trust | 0,62% | 25.194 NS | 30 de Abril de 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,37% | 62.972 NS | 31 de Maio de 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,37% | 103.377 NS | 31 de Maio de 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 113.111 NS | 30 de Abril de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,08% | 123.628 SH | 8 de Agosto de 2026 | Diário |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 1.220.658 NS | 31 de Maio de 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,06% | 51.988 SH | 8 de Agosto de 2026 | Diário |
| IWC · iShares Trust | 0,06% | 164.733 SH | 8 de Agosto de 2026 | Diário |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,04% | 1.939.936 NS | 31 de Maio de 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 63.063 NS | 31 de Maio de 2026 | N-PORT |
| VDC · VANGUARD WORLD FUND | 0,03% | 570.468 SH | 8 de Agosto de 2026 | Diário |
| EBIT · Harbor ETF Trust | 0,03% | 435 NS | 30 de Abril de 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,02% | 242.807 NS | 30 de Abril de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 42.579 SH | 8 de Agosto de 2026 | Diário |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 90.212 NS | 31 de Maio de 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 492.546 SH | 8 de Agosto de 2026 | Diário |
| DFAT · Dimensional ETF Trust | 0,01% | 253.656 NS | 30 de Abril de 2026 | N-PORT |
| SMLF · iShares Trust | 0,01% | 108.807 SH | 8 de Agosto de 2026 | Diário |
| RSSL · Global X Funds | 0,01% | 20.906 NS | 30 de Abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 280.867 SH | 8 de Agosto de 2026 | Diário |
| SFGV · EA Series Trust | 0,01% | 27.758 NS | 29 de Maio de 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.306.883 SH | 8 de Agosto de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,01% | 161.524 NS | 30 de Abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2.272 NS | 31 de Maio de 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 13.837 NS | 31 de Maio de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 236.168 NS | 31 de Maio de 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1.776 NS | 31 de Maio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.999 NS | 30 de Abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1.797 NS | 31 de Maio de 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 33.427 SH | 8 de Agosto de 2026 | Diário |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 38.038 NS | 31 de Maio de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.714 NS | 31 de Maio de 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 1.031 NS | 31 de Maio de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 45 NS | 31 de Maio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.155 NS | 30 de Abril de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2.509 NS | 30 de Abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.479 NS | 30 de Abril de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 69.546 SH | 8 de Agosto de 2026 | Diário |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 27.870 NS | 31 de Maio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 12.071 SH | 8 de Agosto de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,00% | 6.548 NS | 30 de Abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 562.165 SH | 8 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.465.550 SH | 8 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.734 SH | 8 de Agosto de 2026 | Diário |
| EBI · RBB Fund Trust | 0,00% | 3 NS | 31 de Maio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1.362 NS | 30 de Abril de 2026 | N-PORT |